Baxter International BAX
-
New Morningstar Analyst Report - Hospira, Inc.
… division, injectable pharmaceuticals , is a niche in the generic pharmaceuticals market. Conventional ..... managers. Injectable pharmaceuticals require more advanced ..... with CareFusion CFN and Baxter BAX account for about 60 …
-
Baxter Still Defensive, But Is Now The Time For Offense?
… Stephen Simpson : The best thing about Baxter ( BAX ) is that so much of its business ..... reimbursement. The worst thing about Baxter is that so much of its business comes ..... demand and reimbursement. In theory, Baxter is a good stock to own during slow …
-
3 Medical Device Stocks That Are Meaningfully Undervalued
… through my DCF model on Medtronic ( MDT ) and then triangulate the result against a review of the fundamentals compared to Baxter ( BAX ) and Abbott. I find all three meaningfully undervalued. For an industry as safe as medical devices, you would expect …
-
CareFusion's Medical Device Segment Reports Stronger-Than-Expected Results
… the infusion pump segment suggest management has been successful in taking market share from its competitors during the Baxter BAX pump recall situation. While CareFusion’s infusion pump sales should decline next year since industry demand has …
-
Momenta's Revenue Collapses on Competing Generic Lovenox Launch
… to make a few adjustments to our model after Momenta Pharmaceuticals MNTA reported first-quarter results with a 69% revenue ..... received the up-front $33 million cash payment from Baxter BAX in the quarter. We're maintaining our operating cost …
-
This Stock Has Room For Capital Appreciation And Dividend Growth
… the industry (15.4%). The much larger Baxter International ( BAX ), is the only other company with a higher ..... Scientific, Inc. ( TMO ) 10.2x 8.7% Baxter International Inc . BAX 11.0x 16.2% PerkinElmer Inc. ( PKI …
-
Baxter International's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Baxter International ( BAX ) Q1 2012 Earnings Call April 19, 2012 8:30 am ET Executives ..... Operator Good morning, ladies and gentlemen, and welcome to Baxter International 's First Quarter Complete Story »
-
Maintaining Baxter's Fair Value Estimate After First-Quarter Results, On Track to Meet 2012 Forecast
Baxter 's BAX first-quarter results put the firm on ..... modestly above our current estimate for 2012. Baxter continues to bet on the long-term growth ..... digit growth from this business, which Baxter dominates along with Australia firm CSL …
-
UPDATE 1- Baxter 1st-qtr earnings top expectations
April 19 (Reuters) - Baxter International Inc reported better-than-expected first-quarter earnings on Thursday, helped by an acquisition and strong demand for its treatments for hemophilia and immune deficiencies.
-
CORRECTED- Baxter Q1 earnings top expectations
April 19 (Reuters) - Baxter International Inc reported better-than-expected first-quarter earnings on Thursday, helped by an acquisition and strong demand for its treatments for hemophilia and immune deficiencies.